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A B S T R A C T
Background
Amblyopia is a reversible deficit of vision that has to be treated within the sensitive period for visual development. Screening programmes
have been set up to detect this largely asymptomatic condition and refer children for treatment while an improvement in vision is still
possible. The value of such programmes and the optimum protocol for administering them remain controversial.
Objectives
The objective of this review was to evaluate the effectiveness of vision screening in reducing the prevalence of amblyopia.
Search strategy
We searched the Cochrane Central Register of Controlled Trials (The Cochrane Library Issue 3, 2008), MEDLINE (January 1950 to
August 2008) and EMBASE (January 1947 to August 2008). The electronic databases were last searched on 15 August 2008. No
language restrictions were placed on these searches. No handsearching was done.
Selection criteria
We planned to analyse data from randomised controlled trials and cluster-randomised trials comparing the prevalence of amblyopia in
screened versus unscreened populations.
Data collection and analysis
Two authors independently assessed study abstracts identified by the electronic searches. Full text copies of appropriate studies were
obtained and, where necessary, authors were contacted. No data were available for analysis and no meta-analysis was performed.
Main results
Despite the large amount of literature available regarding vision screening no trials designed to compare the prevalence of amblyopia
in screened versus unscreened populations were found.
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Authors’ conclusions
The lack of data from randomised controlled trials makes it difficult to analyse the impact of existing screening programmes on the
prevalence of amblyopia. The absence of such evidence cannot be taken to mean that vision screening is not beneficial; simply that
this intervention has not yet been tested in robust trials. To facilitate such trials normative data on age-appropriate vision tests need
to be available and a consensus reached regarding the definition of amblyopia. In addition, the consequences of living with untreated
amblyopia have yet to be quantified and a cost-benefit analysis carried out.
P L A I N L A N G U A G E S U M M A R Y
Vision screening programmes for amblyopia (lazy eye)
Amblyopia, commonly known as “lazy eye”, is the term used to describe a type of reduced vision that develops in childhood. Amblyopia
is relatively common, affecting approximately 2% of children. If treated while the visual system is still maturing amblyopia can usually
be reversed and normal vision restored. In most cases amblyopia only affects one eye so even quite severe amblyopia may go unnoticed
by parents or caregivers. Screening programmes have, therefore, been set up to test children’s vision, in each eye separately, in order to
detect the condition while the child is young and treatment is still possible. This review was designed to examine the evidence to see if
such screening programmes are effective in reducing the prevalence of untreated amblyopia. The review found that there is currently
not enough evidence to determine whether or not screening programmes reduce the proportion of older children and adults with
amblyopia. The authors concluded that there is, therefore, a need for some robust evaluation of the screening programmes that are in
place to see if they are truly effective or not. Any such evaluation would have to also look at how much screening programmes cost and
what effect untreated amblyopia has on quality of life.
B A C K G R O U N D
Introduction
Amblyopia (lazy eye) can be defined as a reduction in vision with
no demonstrable abnormality of the visual pathway that is not
immediately resolved by refractive correction. It develops during
maturation of the visual pathway and is reversible during the first
seven to eight years of life. This is known as the ’critical period’.
In some situations the critical period may be extended (Simmers
1999). The developing visual system relies on good quality visual
images. Amblyopia can develop when the image coming into one
or both eyes is either blurred or obscured. It develops through
an abnormal binocular cortical interaction and results in a loss of
acuity, contrast sensitivity, and/or positional disorder (Levi 1999).
Amblyopia is usually classified by cause:
(1) strabismic when it is due to the presence of a squint;
(2) anisometropic where the refractive error is significantly greater
for one eye than the other (a difference of more than or equal to
0.75 dioptre is generally thought to be significant);
(3) meridional where there is a significant degree of astigmatism
(more than or equal to 1.00 dioptre) ;
(4) stimulus deprivation where, for example, a cataract or ptosis
(droopy lid) obscures the visual axis;
(5) ametropic where the refractive error is such that neither eye
receives a good quality image.
It is not uncommon for the types to co-exist.
Epidemiology
Amblyopia is a common cause of reduced visual acuity. Estimates
of the prevalence of amblyopia vary between 2% and 5%. Factors
that contribute to the range of estimates include the population
studied and the definition of amblyopia applied. It is, however,
widely accepted that in the general population the incidence is
between 2% and 2.5% (von Noorden 1996). For the purposes of
this review, in order to be able to include as many trials as possible,
amblyopia was defined as visual acuity of worse than 6/9 Snellen
or 0.2 LogMAR in the affected eye or eyes.
Screening
Untreated amblyopia canhave a negative impact in adult life. Some
career choices have specific visual acuity requirements. The num-
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ber of careers barred to adults with reduced vision increases with
the severity of the deficit (Adams 1999) and a national surveil-
lance study in 2002 in the UK found that only 35% (36/102) of
people who lost the vision in their non-amblyopic were able to
continue in paid employment (Rahi 2002). A minimum lifetime
risk of 1.2% of serious visual impairment through loss of acuity
in the eye with the better vision, for example from trauma, age-
related retinal changes (ARMD) and circulation problems (retinal
vein and artery occlusions etc.) has been estimated (Rahi 2002).
Screening programmes have therefore been introduced to detect
amblyopia during the assumed critical period while treatment is
possible.
Vision screening programmes for amblyopia rely on the reduced
visual acuity associated with the condition as a marker for the
disease. Any screening programme aiming to detect amblyopia
this way will, inevitably, also pick up children with other causes of
reduced vision, for example uncorrected refractive error.
Currently there are a variety of recommendations for vision screen-
ing programmes and a number of different approaches to provid-
ing the service. Protocols vary not only from country to coun-
try but within countries. The battery of tests carried out usually
includes monocular visual acuity testing with an age-appropriate
test, plus or minus assessment of extra-ocular muscle function,
binocular status, and colour vision assessment. Protocols vary with
regard to the vision and binocular function test used, threshold for
referral, and age at which children are screened. The type of per-
sonnel carrying out the testing varies, for example doctors, nurses,
orthoptists, as does the setting. Some screening programmes are
conducted in a community setting. This type of programme allows
early screening to take place but makes achieving a high coverage
rate more difficult. They may have unacceptably high false posi-
tive and recall rates because the participants are too young to co-
operate with testing. To overcome this some programmes are set
up to screen children during their first year at school. Whilst this
should improve the percentage reached by screening and decrease
the number of false positives it is possible that later treatment of
any detected amblyopia may not have such good outcomes.
Most screening programmes for amblyopia are to be found in
the developed world and urban areas of the developing world.
They can be part of the government health care system or private,
commercially driven schemes.
Screening has a role not only in detection of the target condition
but also in improving equity of access to care. This review consid-
ered screening programmes for children with amblyopia. Studies
that included screening for refractive error, for example photore-
fraction studies and fundus screening programmes, have not been
included in this review. Vision screening for myopia in schools is
considered in another review (Powell 2004).
Presentation and diagnosis
Some types of amblyopia present because they are associated with
signs, for example strabismus or ptosis. However, ’straight-eyed’
(anisometropic) amblyopia may not be noticed by the parent or
the child as it commonly affects only one eye and has no visible
signs. Affected children are therefore detected as a result of vision
screening programmes.
There are four main steps in the diagnosis of amblyopia:
1. monocular visual acuity assessment using an age-appropriate
vision test;
2. refraction. Although autorefraction is relatively quick and easy
to perform, retinoscopy is recommended. In young children a
topical drug such as cyclopentolate hydrochloride is required to
paralyse accommodation as most young children are unable to
maintain distance fixation during testing;
3. fundus and media examination to exclude any pathology;
4. rechecking the visual acuity with the glasses correction in place.
During the critical period some improvement in visual acuity is
expected after wearing the appropriate spectacle correction. This
is traditionally a period of about six weeks but evidence suggests
that improvement continues up to twelve weeks (Moseley 2002).
The diagnosis is made if a visual acuity deficit persists after the
refractive error has been corrected for a period.
Treatment options
Screening is intended to reduce the prevalence of a condition and
has to facilitate referral for treatment. The impact of vision screen-
ing will therefore depend partly on the success of subsequent treat-
ment for amblyopia. Treatment for amblyopia broadly consists of
a combination of spectacle correction, patching or ’penalisation’
of the better-seeing eye using drugs or lenses. Treatment options
and the management plan will depend on the type of amblyopia
diagnosed. Factors affecting the outcome of treatment include the
age of the patient and the density of the amblyopia. Compliance
with treatment prescribed is also very important so available treat-
ment has to be acceptable to the patient and their parents.
The effectiveness of various interventions for amblyopia is being
examined in a series of Cochrane reviews (Antonio-Santos 2006;
Shotton 2008). Citations for the others will be provided in updates
to this review as they reach publication.
Treatment outcomes can be quantified by measuring the change
in acuity in the amblyopic eye either as:
1. the number of lines change in visual acuity at the end of treat-
ment;
2. the proportion of the visual acuity deficit that has been corrected
(Stewart 2003); or
3. final visual acuity on an age specific test.
A final visual acuity of 6/9 Snellen or 0.2 LogMAR or better is
generally agreed to represent the restoration of normal vision.
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Rationale for a systematic review
Amblyopia is a commonly occurring, usually monocular condi-
tion that needs to be treated within the critical period for visual
development in order for treatment to be effective. School-entry
and preschool screening programmes have therefore been intro-
duced to detect amblyopia while the condition is still amenable
to treatment. Uncertainty regarding the value of such screening
programmes exists (Hall 2003; Snowden 1997). A major review
of vision screening in the UK (Snowden 1997) highlighted the
need for good quality research into the natural history of ambly-
opia and the outcomes of treatment for the condition. There is a
need to examine existing evidence to establish the impact of vision
screening and subsequent treatment on the prevalence of ambly-
opia and to consider the possible harms that might arise from this
intervention.
O B J E C T I V E S
The primary objective of this review was to evaluate the impact
of vision screening on the prevalence of amblyopia in comparable
screened versus unscreened populations. Subgroup analyses were
planned to determine the effect of the type of personnel conduct-
ing the testing, the age at screening, and the visual acuity thresh-
old at which participants are referred for further evaluation. Sec-
ondary objectives were to report available evidence regarding the
disability associated with living with uncorrected amblyopia and
to document reports of the potential harms and costs associated
with screening.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials, including cluster-randomised trials,
were considered for inclusion. No language or date restrictions
were imposed.
Types of participants
Trials in which participants had been screened before they started
school or as they entered school were eligible for inclusion. Trials
which included participants with a pathological barrier to vision,
for example retinal or corneal dystrophy or cataract, identified by
post-screening fundus and media examination were excluded.
Types of interventions
Trials in which the intervention was screening by formal visual
acuity testing were eligible for inclusion. We intended to include
studies in which screening was carried out by monocular visual
acuity (VA) assessment using any age-appropriate vision test, any
threshold for failure, and administered by any testing personnel,
measuring:
1. distance VA only or,
2. near and distance VA.
The following comparison was planned:
• screening to no screening.
Subgroup analyses were planned to look at the effect of:
• the visual acuity threshold applied for failing screening;
• who administered the screening;
• the age of the participants;
• a failure threshold of worse than 6/9 Snellen to a threshold
of 6/9 Snellen or better;
• testing personnel with different professional qualifications,
for example nurses, teachers, and eye trained personnel;
• participants screened under the age of five years and those
screened aged five years and over
Types of outcome measures
Primary outcomes
The primary outcome for this review was the prevalence of am-
blyopia in comparable screened versus unscreened populations 12
months from screening. It was intended to discuss prevalence data
in the context of whether amblyopia treatment was on-going or
discharge visual acuities were reported and whether or not partic-
ipants were still within the critical period for visual development
at that stage.
Secondary outcomes
Secondary outcomes for this review were:
1. the prevalence of amblyopia at other periods of follow up. It
was intended to report prevalence data at other time periods of
follow up as collected by included studies;
2. coverage rates achieved by screening programmes in different
settings (for example preschool and school-entry screening pro-
grammes) defined by the percentage of the target population that
was actually screened.
Search methods for identification of studies
Electronic searches
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We searched the Cochrane Central Register of Controlled Tri-
als (CENTRAL) (which contains the Cochrane Eyes and Vision
Group Trials Register) (The Cochrane Library, Issue 3, 2008),
MEDLINE (January 1950 to August 2008) and EMBASE (Jan-
uary 1947 to August 2008).There were no language or date re-
strictions in the search for trials. The electronic databases were last
searched on 15 August 2008.
See: Appendices for details of search strategies for CENTRAL
(Appendix 1),MEDLINE (Appendix 2) andEMBASE (Appendix
3).
Searching other resources
No manual searches were conducted.
Data collection and analysis
Assessment of search results
Two authors independently assessed the titles and abstracts identi-
fied by the searches to establish whether any met the inclusion cri-
teria for this review. Full text copies of potentially eligible studies
were obtained and, where necessary, trial authors were contacted.
No trials met the inclusion criteria and, therefore, none were as-
sessed for quality and no data were extracted or analysed.
Updates to this review
If relevant trials become available in the future theywill be included
in the review using the following methods.
Assessment of methodological quality
We will assess the methodological quality of included studies by
examining four main sources of bias:
1. selection bias: controlled by randomisation and allocation con-
cealment;
2. detection bias: whether or not examiners responsible for mea-
suring outcomes were masked to the group allocation of partici-
pants;
3. attrition bias: how participants lost to follow up were accounted
for. We will consider whether follow-up rates for groups were
similar and whether all participants were analysed as randomised,
that is, whether an intention to treat analysis was performed;
4. performance bias: - the masking of participants and care
providers to the group allocation.
Each parameterwill be graded as (A) yes, requirementsmet; (C) no,
requirements not met; or (B) unable to determine. Clarification
will be sought from trial authors of studies graded B. We will
exclude in sensitivity analyses studies graded B or C to examine
whether they have an impact on the size and direction of effect.
Data collection
Two authors independently will extract data using the Cochrane
Eyes and Vision Group data collection form and enter data into
RevMan 5.0.
Data synthesis
We will check studies included in the review for heterogeneity by:
1. examining the characteristics of the included studies;
2. looking for poor overlap of the confidence intervals on the forest
plot;
3. the result of the chi squared test.
If appropriate a meta-analysis was to be carried out using the
RevMan 5.0 software. The fixed-effect model will be used if there
are fewer than three trials to analyse. If more trials are included
the random-effects model will be used.
It is anticipated that there will be two sets of data: screening versus
no screening (intervention versus no treatment), and one screening
protocol compared to another. These will be analysed separately.
We anticipate that within each group the proportion of partici-
pants with and without amblyopia would be reported as an out-
come measure, that is, dichotomous data. We will use the risk ra-
tio as the measure of effect. For continuous data we will present
the weighted mean difference. If included studies use different
instruments to measure outcomes but are similar enough to be
combined the standardised mean difference will be calculated.
We will undertake subgroup analysis to examine the impact on
the size and direction of effect of:
• failure thresholds of 6/9 Snellen or 0.2 LogMAR or better
and worse than 6/9 Snellen or 0.2 LogMAR;
• the screening personnel, for example teachers, school nurses
and eye trained professionals;
• the age of participants at screening (under five years of age
at screening compared to five years of age and over) .
Cluster trials will be dealt with according to the guidelines in
Chapter 16 of the Cochrane Handbook for Systematic Reviews of
Interventions (Higgins 2008).
Sensitivity analysis
We will conduct the following sensitivity analyses:
1. excluding trials graded C on any aspect of methodological qual-
ity;
2. excluding trials graded B or C on any aspect of methodological
quality;
3. excluding industry funded studies;
4. excluding unpublished studies.
R E S U L T S
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Description of studies
See: Characteristics of excluded studies.
Results of the search
The electronic searches retrieved 197 references fromThe Cochrane
Library, 655 references fromMEDLINE and 979 references from
EMBASE. After deduplication the search identified a total of 1449
references. After independent review of the titles and abstracts by
two review authors, three papers were retrieved in full. Two of
these papers (Williams 2002; Williams 2003) were from a single
study comparing intensive screening from eight months of age
with a one-off vision screen at 37 months. In addition, in theory,
all participants would have been screened again at school entry.
All participants who were identified as having amblyopia, at any
point, were referred for treatment. The authors were contacted
but data were not available for children who had missed screening
completely. This study was excluded. The third paper (Rasmussen
2000) described a randomised trial of screening for strabismus
and was not designed as a trial of screening for amblyopia. In
addition, the participants were screened using a stereoacuity test
and visual acuity data were not reported. This study was therefore
also excluded.
Risk of bias in included studies
Since no trials have been included in the review none were assessed
for methodological quality.
Effects of interventions
Since no randomised trials comparing the prevalence in screened
versus unscreened populations were found no data were collected
or analysed. No studies attempting to evaluate the possible harms
associated with screening or quantifying the impact of living with
amblyopia were identified.
D I S C U S S I O N
The primary aim of vision screening children at preschool and
school entry is to reduce the prevalence of amblyopia by refer-
ring children for treatment while the condition is still amenable
to treatment. This review was designed to evaluate the evidence
available from randomised controlled trials on the effectiveness
of current screening practices in achieving this. At present there
are no data available from such trials reporting prevalence rates
of amblyopia in screened versus unscreened populations. A small
selection of papers identified by the electronic searches and some
from their citation lists which describe current practice will there-
fore be discussed. These studies cannot be regarded as having been
systematically retrieved and assessed for bias in the same way that
randomised controlled trials would have been.
Prevalence of amblyopia in screened cohorts
The electronic searches did not find any randomised controlled
trials designed to evaluate the impact of vision screening on the
proportion of amblyopia. The evidence available is from observa-
tional studies of screened populations.
The lack of a universally-accepted definition of amblyopia makes
data from published studies of screened populations difficult to
compare. Setting the definition as visual acuity of worse than 6/
9 Snellen studies have reported estimates of between 0.63% and
1.81% (Bray 1996; Jensen 1986; Ohlsson 2001; Williams 2002;
Williams 2003). A summary of the estimates from individual pa-
pers, together with the definition of amblyopia, used can be found
in Table 1.
Jensen 1986 also reported more severe acuity deficits. In 1986
0.73% of the study population had a best-corrected uniocular
visual acuity of 6/18 Snellen or worse. They compared this to the
3.2% reported by Knudtzon 1941 prior to the introduction of
vision screening and concluded that screening has had a significant
impact on the incidence of dense amblyopia.
Coverage rates
Screening children before school entry presents challenges in terms
of the coverage achieved. In general, programmes conducted at
school entry or as part of other healthcare checks report reaching a
much higher percentage of the target population. In Scandinavia,
where preschool vision screening is carried out when the child
attends for other general health checks, coverage is reported to be
99% (Kvarnstrom 2001).
InNewcastle, UK a prospective comparative evaluation found that
only 58% (916/1582) of children invited for preschool screening
attended compared to an estimate of more than 95% for the local
school-entry vision screening programme (Bray 1996). Where a
large percentage of the population remains unscreened the poten-
tial benefits of a screening programme are significantly reduced.
An intention-to-screen analysis carried out by the ALSPAC team,
who conducted a prospective trial in the UK, demonstrated that
obtaining only 67% coverage, as they did, reduced the benefit at-
tributable to early screening to a level undetectable by a study of
that size (Williams 2003).
What is the optimum age to screen for
amblyopia?
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One of the dilemmas when designing a vision screening pro-
gramme is that whilst screening at school entry is likely to improve
coverage there is a concern that visual outcomes may not be as
favourable as if the detection and treatment had occurred earlier.
Williams 2003, as part of the ALSPAC study, compared the out-
comes of treatment for a cohort of children screened preschool
(at 37 months) to those who were screened at school entry. This
study did report slightly better outcomes in the preschool group
(mean visual acuity of 0.14 LogMAR, Standard Deviation(SD)
0.18) compared to the school-entry group (mean 0.2 LogMAR,
SD 0.23). A subgroup analysis revealed that this beneficial effect
was statistically significant only for ’straight-eyed’ amblyopia (0.06
compared to 0.12). For amblyopia associated with squint no such
beneficial effect existed (0.27 compared to 0.29).
In Newcastle a randomised controlled trial of glasses and occlusion
therapy for amblyopia identified at screening found no significant
difference in outcome between participants whose treatment be-
gan at 48.1 months and the control group who did not commence
treatment until twelve months later. In both groups the mean vi-
sual acuity six months after the control group had been treated was
0.170 LogMAR (SD 0.15 intervention group and 0.13 in control
group) (Clarke 2003).
Threshold applied for failure
The threshold applied for failing vision screening appears to vary
depending on local or national practice patterns as well as on
the test used and the age at screening. The lack of age-related
normative data adds to the difficulty of interpreting results. In
most countries there appears to be no standardisation.
In Sweden, however, there is a countrywide protocol. In the past
the failure threshold for four year olds was 0.8 decimal (6/7.5
Snellen) but it was observed that many children who were being
referred did not require any treatment. This led to a change in
referral criteria. Now children with marginally reduced vision at
four years of age are re-examined at five. A paper evaluating the
new programme in one city area of Sweden found that only 50%
(16/32) of children re-tested at five needed treatment and none of
these had amblyopia as defined by this review by the age of seven
to eight years (Hard 2002).
Who should conduct screening for amblyopia?
Recommendations regarding who should carry out screening for
amblyopia vary. In America practice varies from state to state and
preschool vision screening is carried out by a variety of profes-
sional, volunteer and lay personnel (Ciner 1999; Ehrlich 1983). In
Sweden nurses carry out a vision screen as part of other healthcare
surveillance checks (Hard 2002). In some places trials of home vi-
sion screening kits for parents have been conducted (Ehrlich 1983;
Yazawa 1992).
In the UK orthoptists have been shown to compare favourably
with other screening personnel. In a comparative trial inNewcastle
estimates of 100%sensitivity and97.1%specificitywere calculated
for orthoptists undertaking vision screening in three year olds.
Health visitors achieved better specificity at 100% but managed
a sensitivity of only 50% (Jarvis 1991). In a retrospective study
in Cornwall orthoptists were reported to achieve a sensitivity of
approximately 90% and a specificity of 99% (Wormald 1991).
In addition, Bray 1996 reported a statistically significant reduc-
tion in the age at presentation for anisometropic amblyopia, mi-
crotropia (squint measuring 10 prism dioptres or less) and pure
refractive error when screening was conducted by orthoptists com-
pared to health visitor and GP screening. Current recommenda-
tions in the UK are therefore that a visual assessment should be
carried out by orthoptists on all children between the ages of four
and five (Hall 2003).
Economic data
There is very little data available on the costs involved in screening
for amblyopia.OneGerman study estimated the cost per orthoptic
screening test to be 15.39 Deutschmarks (DM) compared to DM
71.20 for examination by an ophthalmologist. The total cost of
screening in all German kindergartens was estimated to beDM6.1
million.The cost effectiveness ratiowas calculated to beDM1.421
per case detected. A sensitivity analysis showed that prevalence and
sensitivity had a significant impact on the cost-effectiveness ratio
(Konig 2000).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The optimum protocol for carrying out screening remains unclear.
Some evidence on the outcomes of orthoptic treatment following
screening is available. There seems to be no detrimental effect in
terms of visual outcome to leaving screening until school entry
and this appears to improve the coverage achieved (Bray 1996;
Clarke 2003; Williams 2003). At present there is insufficient ev-
idence from good quality trials to allow the impact of screening
for amblyopia on the prevalence to be accurately measured.
Implications for research
There is a clear need for more reliable evidence of the effectiveness
of vision screening programmes in reducing the prevalence of am-
blyopia. To facilitate this process normative values for commonly-
used vision tests need to be available and a consensus reached
as to what level of visual acuity deficit constitutes amblyopia in
the context of age at testing and vision test used. Data of current
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screening practices including costs, coverage, and positive predic-
tive values need to be collected.The introduction of new screening
programmes may provide opportunities to conduct randomised
controlled trials to allow this intervention to be evaluated.
Although the objective of this review was to assess the impact of
screening on the prevalence of amblyopia it is probable that screen-
ing for amblyopia will also detect children with reduced vision
resulting from other causes such as uncorrected refractive error or
anomalies, for example nystagmus or cataract. It would be useful
to collect data to ascertain the percentages of other conditions de-
tected. This may be particularly important to children who would
not have access to eye care professionals in the absence of screen-
ing.More evidence is needed to elucidate the implications of living
with uncorrected amblyopia and the effects of the early provision
of glasses on the development of refractive error.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Rasmussen 2000 Randomised trial screening for strabismus using a stereoacuity test
Williams 2002 No data available for unscreened participants
Williams 2003 No data available for unscreened participants
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D A T A A N D A N A L Y S E S
This review has no analyses.
A D D I T I O N A L T A B L E S
Table 1. Reported prevalence and amblyopia definitions
Study Reported prevalence Amblyopia definition
Bray 1996 1.00% to 1.20% 6/9 Sn or worse
Jensen 1986 1.07% 6/12 Sn or worse
Ohlsson 2001 1.10% 0.5 dec (6/12 Sn) or worse
Williams 2002 0.70% to 1.30% worse than 6/12 Sn
Williams 2003 0.63% to 1.81% worse than 6/12 Sn
A P P E N D I C E S
Appendix 1. CENTRAL search strategy
#1 MeSH descriptor Vision Screening
#2 MeSH descriptor Vision Tests
#3 MeSH descriptor Mass Screening
#4 MeSH descriptor Color Perception Tests
#5 MeSH descriptor Vision Disorders
#6 vis* near test*
#7 vis* near screen*
#8 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7)
#9 MeSH descriptor Amblyopia
#10 amblyop*
#11 lazy near/3 eye*
#12 MeSH descriptor Strabismus
#13 strabism* or squint*
#14 astigmati* or meridonal
#15 anisometropi*
#16 ammetropi*
#17 (#9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16)
#18 child:kw
#19 MeSH descriptor Infant
#20 child* or infan* or adolesc* or juvenile* or minor* or preschool* or nursery
#21 (#18 OR #19 OR #20)
#22 (#8 AND #17 AND #21)
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Appendix 2. MEDLINE search strategy
1 randomized controlled trial.pt.
2 (randomized or randomised).ab,ti.
3 placebo.ab,ti.
4 dt.fs.
5 randomly.ab,ti.
6 trial.ab,ti.
7 groups.ab,ti.
8 or/1-7
9 exp animals/
10 exp humans/
11 9 not (9 and 10)
12 8 not 11 (1991272)
13 exp vision screening/
14 exp vision tests/
15 exp mass screening/
16 exp color perception tests/
17 exp vision disorders/
18 (vis$ adj3 test$).tw.
19 (vis$ adj3 screen$).tw.
20 or/13-19
21 exp amblyopia/
22 amblyop$.tw.
23 (lazy adj3 eye$).tw.
24 exp strabismus/
25 (strabism$ or squint$).tw.
26 (astigmati$ or meridonal).tw.
27 anisometropi$.tw.
28 ammetropi$.tw.
29 or/21-28
30 exp infant/
31 exp child/
32 (child$ or infan$ or adolesc$ or juvenile$ or minor$ or preschool$ or nursery$).tw.
33 or/30-32
34 20 and 29 and 33
35 12 and 34
The search filter for trials at the beginning of the MEDLINE strategy is from the published paper by Glanville et al (Glanville 2006).
Appendix 3. EMBASE search strategy
1 exp randomized controlled trial/
2 exp randomization/
3 exp double blind procedure/
4 exp single blind procedure/
5 random$.tw.
6 or/1-5
7 (animal or animal experiment).sh.
8 human.sh.
9 7 and 8
10 7 not 9
11 6 not 10
12 exp clinical trial/
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13 (clin$ adj3 trial$).tw.
14 ((singl$ or doubl$ or trebl$ or tripl$) adj3 (blind$ or mask$)).tw.
15 exp placebo/
16 placebo$.tw.
17 random$.tw.
18 exp experimental design/
19 exp crossover procedure/
20 exp control group/
21 exp latin square design/
22 or/12-21
23 22 not 10
24 23 not 11
25 exp comparative study/
26 exp evaluation/
27 exp prospective study/
28 (control$ or prospectiv$ or volunteer$).tw.
29 or/25-28
30 29 not 10
31 30 not (11 or 23)
32 11 or 24 or 31
33 exp vision test/
34 exp mass screening/
35 exp color vision test/
36 exp vision disorder/
37 (vis$ adj3 test$).tw.
38 (vis$ adj3 screen$).tw.
39 or/33-38
40 exp amblyopia/
41 amblyop$.tw.
42 (lazy adj3 eye$).tw.
43 exp strabismus/
44 (strabism$ or squint$).tw.
45 (astigmati$ or meridonal).tw.
46 anisometropi$.tw.
47 ammetropi$.tw.
48 or/40-47
49 exp infant/
50 exp child/
51 (child$ or infan$ or adolesc$ or juvenile$ or minor$ or preschool$ or nursery$).tw.
52 or/49-51
53 39 and 48 and 52
54 32 and 53
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WH A T ’ S N E W
Last assessed as up-to-date: 14 August 2008.
Date Event Description
14 January 2009 Amended One trial (Rasmussen 2000) identified in the electronic searches has been added to the excluded
studies table
H I S T O R Y
Protocol first published: Issue 4, 2004
Review first published: Issue 3, 2005
Date Event Description
17 October 2008 New search has been performed Issue 1, 2009: Updated searches yielded no new trials.
29 July 2008 Amended Converted to new review format.
C O N T R I B U T I O N S O F A U T H O R S
Performing previous work that was the foundation of the current study: SR
Conceiving the review: HP, CP
Designing the review: CP
Coordinating the review: CP
Providing advice: SR
Screening search results: HP, CP, MB
Organising retrieval of papers: CP
Screening retrieved papers against inclusion criteria: HP, CP, MB
Appraising quality of papers: HP, CP, MB
Extracting data from papers: CP, SR
Writing to authors of papers for additional information: CP
Obtaining and screening data on unpublished studies: CP
Data management for the review: CP
Entering data into RevMan: CP
Analysis of data: CP, SR
Interpretation of data: CP, SR
Writing the review: CP, SR
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D E C L A R A T I O N S O F I N T E R E S T
None known.
S O U R C E S O F S U P P O R T
Internal sources
• No sources of support supplied
External sources
• Christian Blind Mission, Germany.
• Sight Savers International, UK.
I N D E X T E R M S
Medical Subject Headings (MeSH)
Amblyopia [∗diagnosis]; ∗Vision Screening
MeSH check words
Child; Child, Preschool; Humans
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